New Group Leader Gopal Sapkota arrived in Dundee on the 1st November to start his laboratory in the TGFbeta signalling pathway. Previously Gopal worked for five years in Joan Massagué's laboratory at the Memorial Sloan-Kettering Cancer Centre, New …more
News
Ian Kelsall, a student in Tricia Cohen's group, successfully defended his PhD thesis entitled "Roles of the glycogen targeting subunits of protein phosphatase 1 in the tissue-specific regulation of glycogen metabolism " on October 23rd 2008. Ian ga …more

Jim Woodgett, who carried out his Ph.D. in Philip Cohen's laboratory over the period 1981-1984, gave an Alumnus Lecture to the MRC-PPU and the College of Life Sciences on October 22nd 2008 entitled 'Genetic analysis of GSK‑3 in insulin and Wnt …more

The Medical Research Council Protein Phosphorylation Unit at the University of Dundee has been awarded £989,000 to set up the UK's National Centre for Protein Kinase Profiling, a unique service which will widen academic access to one of the fastest d …more

Christian, a visiting postdoc to the MRC Unit from the University of TÃÂ_bingen, Germany, is working hard in Dario Alessi's lab at characterising various protein kinase inhibitors. However Christian has also been exploring fishing opportunities in l …more

The University of Dundee and the Medical Research Council (MRC) are pleased to announce new funding of almost £11 million from a consortium of pharmaceutical companies for the Division of Signal Transduction Therapy (DSTT), a groundbreaking collabora …more

Miratul Muqit has started working in the MRC Unit, after being awarded a prestigious Wellcome Trust Intermediate Clinical Fellowship, to carry out research on the Parkinson's disease associated kinases PINK1 and LRRK2. Miratul is a clinical neurologi …more

Peter Parker, a postdoctoral fellow in the MRC-PPU from 1979-1982 has sold the company he founded to Genentech for US $160 million.
Peter founded PIramed with Mike Waterfield, Paul Workman and Srivivas Akkaraju in 2003 to develop small mol …more
Peter founded PIramed with Mike Waterfield, Paul Workman and Srivivas Akkaraju in 2003 to develop small mol …more

Tim Haystead, who worked in Philip Cohen's lab as a scientific officer from 1983-1985 and then carried out his PhD at Dundee with Grahame Hardie, has sold Serenex, the company he founded, to Pfizer for several hundred million US dollars.
T …more
T …more